SS-31 10mg Research Vial — Coming Soon to Peptify UK
SS-31 10mg. SS-31 (Elamipretide) is a mitochondria-targeted peptide researched for its ability to stabilise cardiolipin and improve mitochondrial function, with potential applications in aging and metabolic research. For research use only.
This research peptide is studied in published tissue-repair, recovery, and cytoprotection research literature. SS-31 10mg is supplied strictly as a lyophilised powder for in-vitro and preclinical research applications. Not approved by the MHRA for human therapeutic use; not for human consumption under any circumstances.
This 10mg vial is a mid-range research format sized to balance per-vial cost against reconstitution shelf-life for typical multi-week preclinical protocols.
What ships with the SS-31 10mg vial
- Lyophilised research peptide vial — SS-31 10mg
- Janoshik Analytical Certificate of Analysis specific to the production lot (independent Czech laboratory, not in-house QC)
- HPLC purity report — 99%+ purity standard before any vial is released
- Mass-spectrometry identity confirmation on the same COA
- UK Royal Mail Tracked dispatch from London — same-day if ordered before 1pm
Why SS-31 10mg is currently coming-soon, not in-stock
Every Peptify SKU is held back from sale until the Janoshik Analytical COA arrives for the specific production lot. This is a deliberate stock-control policy — no batch ships before its certificate is in our hands, no exceptions. The SS-31 10mg batch is in the Janoshik test queue; this product page will flip from "Coming Soon" to "Add to basket" the moment the lot-specific COA lands.
Background literature on this compound is collected on the Peptify SS-31 research hub, which catalogues published preclinical findings, mechanism-of-action notes, and reference half-life data — all sourced and citation-anchored.
Stock alert sign-up
Enter your email on this page to be notified when SS-31 10mg is released. Stock alerts go out the same hour the COA is uploaded — no marketing emails, no list-rental, just the one stock-back notification.
Supplier & compliance
PEPTIFY LIMITED is registered at Companies House under company number #17021295, incorporated 9 February 2026. Registered office: 6th Floor, 37 Lombard Street, London, EC3V 9BQ. UK IPO trademark applications under prosecution: UK00004350730 (word mark) and UK00004378672 (combined mark). All Peptify research peptides are sold for laboratory and preclinical research use only.
For research use only. Not for human consumption.